SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-23-002583
Filing Date
2023-02-15
Accepted
2023-02-15 12:54:16
Documents
1
Period of Report
2022-12-12

Document Format Files

Seq Description Document Type Size
1 form4a-02152023_050206.html 4/A  
1 form4a-02152023_050206.xml 4/A 4425
  Complete submission text file 0001415889-23-002583.txt   5821
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Issuer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address
Duncan Gregory Scott (Reporting) CIK: 0001831127 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39811 | Film No.: 23634657